JP2022521824A5 - - Google Patents
Info
- Publication number
- JP2022521824A5 JP2022521824A5 JP2021557651A JP2021557651A JP2022521824A5 JP 2022521824 A5 JP2022521824 A5 JP 2022521824A5 JP 2021557651 A JP2021557651 A JP 2021557651A JP 2021557651 A JP2021557651 A JP 2021557651A JP 2022521824 A5 JP2022521824 A5 JP 2022521824A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- inhibitor
- pharmaceutical composition
- combination according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962825450P | 2019-03-28 | 2019-03-28 | |
| US62/825,450 | 2019-03-28 | ||
| US201962842980P | 2019-05-03 | 2019-05-03 | |
| US62/842,980 | 2019-05-03 | ||
| US201962857519P | 2019-06-05 | 2019-06-05 | |
| US62/857,519 | 2019-06-05 | ||
| PCT/US2020/025539 WO2020198710A1 (en) | 2019-03-28 | 2020-03-27 | Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521824A JP2022521824A (ja) | 2022-04-12 |
| JP2022521824A5 true JP2022521824A5 (https=) | 2023-04-04 |
Family
ID=72610726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557651A Ceased JP2022521824A (ja) | 2019-03-28 | 2020-03-27 | アンドロゲン受容体の阻害剤を含む薬学的組成物及びその組み合わせならびにその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220202780A1 (https=) |
| EP (1) | EP3947353A4 (https=) |
| JP (1) | JP2022521824A (https=) |
| KR (1) | KR20210144827A (https=) |
| CN (1) | CN114502539A (https=) |
| AU (1) | AU2020248105A1 (https=) |
| CA (1) | CA3134545A1 (https=) |
| IL (1) | IL286726A (https=) |
| MX (1) | MX2021011826A (https=) |
| WO (1) | WO2020198710A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016141458A1 (en) | 2015-03-12 | 2016-09-15 | British Columbia Cancer Agency Branch | Bisphenol ether derivatives and methods for using the same |
| US20170298033A1 (en) | 2016-04-15 | 2017-10-19 | The University Of British Columbia | Bisphenol derivatives and their use as androgen receptor activity modulators |
| US11485713B2 (en) | 2018-05-25 | 2022-11-01 | Essa Pharma, Inc. | Androgen receptor modulators and methods for their use |
| WO2020051424A1 (en) | 2018-09-07 | 2020-03-12 | Pic Therapeutics | Eif4e inhibitors and uses thereof |
| WO2020198712A1 (en) | 2019-03-28 | 2020-10-01 | Essa Pharma, Inc. | Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof |
| CR20220160A (es) | 2019-09-16 | 2022-06-16 | Takeda Pharmaceuticals Co | Derivados de piridazin-3(2h)-ona fusionados con azol |
| JP2021050161A (ja) | 2019-09-25 | 2021-04-01 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
| JP2021080177A (ja) | 2019-11-14 | 2021-05-27 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
| TW202146393A (zh) | 2020-03-03 | 2021-12-16 | 美商皮克醫療公司 | Eif4e抑制劑及其用途 |
| CN115916170A (zh) | 2020-04-17 | 2023-04-04 | 埃萨制药股份有限公司 | 固体形式的n-末端结构域雄激素受体抑制剂及其用途 |
| WO2022060969A1 (en) * | 2020-09-16 | 2022-03-24 | Essa Pharma, Inc. | Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof |
| WO2022169248A1 (ko) * | 2021-02-02 | 2022-08-11 | 주식회사 엘지화학 | 단백질 키나아제 억제제로서의 신규한 화합물 |
| US20240207264A1 (en) * | 2021-04-16 | 2024-06-27 | Essa Pharma Inc. | Pharmaceutical compositions comprising inhibitors of the androgen receptor and uses thereof |
| CN115340527B (zh) * | 2021-05-13 | 2023-09-15 | 成都先导药物开发股份有限公司 | 一种bcl-xl抑制剂及其制备方法和用途 |
| CN113603695B (zh) * | 2021-08-05 | 2022-06-14 | 青岛恒宁生物科技有限公司 | 一种取代的嘧啶胺类化合物或其作为农药可接受的盐、组合物及其用途 |
| US12157732B2 (en) | 2021-08-25 | 2024-12-03 | PIC Therapeutics, Inc. | eIF4E inhibitors and uses thereof |
| CA3229560A1 (en) | 2021-08-25 | 2023-03-02 | Christopher L. Vandeusen | Eif4e inhibitors and uses thereof |
| WO2023031371A1 (en) * | 2021-09-01 | 2023-03-09 | Janssen Pharmaceutica Nv | Combination therapies for metastatic castration-resistant prostate cancer |
| AU2022340817A1 (en) * | 2021-09-01 | 2024-03-14 | Essa Pharma Inc. | Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof |
| WO2023151662A1 (zh) * | 2022-02-10 | 2023-08-17 | 上海奕拓医药科技有限责任公司 | 雄激素受体活性调节剂及其应用 |
| CN117065022A (zh) * | 2022-05-17 | 2023-11-17 | 海创药业股份有限公司 | 一种治疗三阴乳腺癌的药物 |
| WO2024006207A1 (en) * | 2022-06-26 | 2024-01-04 | Essa Pharma Inc. | An n-terminal domain androgen receptor inhibitor and uses thereof |
| EP4626878A1 (en) | 2022-12-02 | 2025-10-08 | Neumora Therapeutics, Inc. | Methods of treating neurological disorders |
| CN121698845A (zh) * | 2024-09-12 | 2026-03-20 | 青岛普泰科生物医药科技有限公司 | 一种四氢喹啉类ntd抑制剂及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2656842T1 (sl) * | 2006-03-27 | 2016-10-28 | The Regents Of The University Of California | Modulator androgenih receptorjev za zdravljenje raka prostate in bolezni, povezanih z androgenimi receptorji |
| US20130045204A1 (en) * | 2011-08-19 | 2013-02-21 | The University Of British Columbia | Fluorinated bisphenol ether compounds and methods for their use |
| LT2872482T (lt) * | 2012-07-13 | 2020-12-28 | Oncternal Therapeutics, Inc. | Krūties vėžių gydymo būdas selektyviu androgeno receptoriaus moduliatoriumi |
| DK3988541T3 (da) * | 2015-01-13 | 2024-09-16 | British Columbia Cancer Agency Branch | Heterocycliske forbindelser til billedscanning og behandling af cancer samt fremgangsmåder til anvendelse af disse |
| US10980806B2 (en) * | 2016-03-24 | 2021-04-20 | University of Pittsburgh—of the Commonwealth System of Higher Education | Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer |
| US20170298033A1 (en) * | 2016-04-15 | 2017-10-19 | The University Of British Columbia | Bisphenol derivatives and their use as androgen receptor activity modulators |
| MX389702B (es) * | 2016-06-22 | 2025-03-20 | Ellipses Pharma Ltd | Compuestos para usarse en el tratamiento de cancer de mama que expresa el receptor de androgenos (ar+). |
| WO2020081999A1 (en) * | 2018-10-18 | 2020-04-23 | Essa Pharma, Inc. | Androgen receptor modulators and methods for their use |
-
2020
- 2020-03-27 CA CA3134545A patent/CA3134545A1/en active Pending
- 2020-03-27 AU AU2020248105A patent/AU2020248105A1/en not_active Abandoned
- 2020-03-27 KR KR1020217034804A patent/KR20210144827A/ko not_active Ceased
- 2020-03-27 MX MX2021011826A patent/MX2021011826A/es unknown
- 2020-03-27 CN CN202080039623.3A patent/CN114502539A/zh active Pending
- 2020-03-27 EP EP20779267.2A patent/EP3947353A4/en not_active Withdrawn
- 2020-03-27 US US17/599,338 patent/US20220202780A1/en not_active Abandoned
- 2020-03-27 JP JP2021557651A patent/JP2022521824A/ja not_active Ceased
- 2020-03-27 WO PCT/US2020/025539 patent/WO2020198710A1/en not_active Ceased
-
2021
- 2021-09-26 IL IL286726A patent/IL286726A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022521824A5 (https=) | ||
| JP7094456B2 (ja) | Ｃｄｋ２阻害剤 | |
| JP6505013B2 (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JP6172871B2 (ja) | ヘテロアリール‐ケトン縮合アザデカリン糖質コルチコイドレセプター調節因子 | |
| KR102515507B1 (ko) | 알파 v 인테그린 억제제로서의 피롤 아미드 | |
| JP5525812B2 (ja) | Ｍｅｋインヒビターとしての新規ヘテロアリール置換アリールアミノピリジン誘導体 | |
| JP2022504949A5 (https=) | ||
| KR102510858B1 (ko) | 알파 v 인테그린 억제제로서의 아졸 아미드 및 아민 | |
| TWI757722B (zh) | 以雜環化合物作為激酶抑制劑的治療用途 | |
| TW201922722A (zh) | 作為法尼醇x受體調節劑之橋聯雙環化合物 | |
| KR20220101137A (ko) | Lpa 수용체 길항제로서의 트라이아졸 카르바메이트 피리딜 설폰아미드 및 이의 용도 | |
| KR20180088457A (ko) | 벤조티오펜-기반 선택적 에스트로겐 수용체 하향조절제 | |
| JP2010018616A (ja) | チロシンキナーゼおよびセリン／スレオニンキナーゼのインヒビターとしてのインダゾールベンズイミダゾール化合物 | |
| CN104010639A (zh) | 作为RORγt调节剂的酰胺类化合物及其应用 | |
| JPWO2000004014A1 (ja) | 抗腫瘍活性を有するピリミジン誘導体 | |
| TWI759343B (zh) | 新穎萘啶酮衍生物及其於心律不整之治療的用途 | |
| AU2005275279A1 (en) | Arylidenes for the treatment of estrogen related receptor-alpha mediated diseases | |
| CN107814798B (zh) | 3-取代丙烯酸类化合物及其制备方法和用途 | |
| KR20190117582A (ko) | 벤조티오펜 에스트로겐 수용체 조정제 | |
| JP2002088073A (ja) | 抗アンドロゲン剤 | |
| CA2803055A1 (en) | Heteroaryl compounds and compositions as protein kinase inhibitors | |
| KR20200081435A (ko) | 파르네소이드 x 수용체 조정제로서의 멀티시클릭 화합물 | |
| AU2020371836A1 (en) | Pyrrole amide compound and use thereof | |
| EP4581024A1 (en) | Substituted heterocycles as ras inhibitors | |
| JP6500092B2 (ja) | Ｔ型カルシウムチャンネルブロッカーとしてのトリアゾール化合物 |